Life-Threatening Errors With Flecainide Suspension in Children

Area of Science:

• Pediatric Pharmacology
• Clinical Pharmacy
• Drug Safety

Background:

• Flecainide is an important antiarrhythmic medication used in pediatric patients.
• Accurate dosing and administration are crucial for effective and safe pediatric treatment.
• Suspension formulations can present unique challenges in pediatric medication delivery.

Purpose of the Study:

• To identify and analyze errors associated with the use of flecainide suspension in a pediatric population.
• To understand the types and frequency of errors in flecainide suspension administration.
• To provide insights for improving the safe use of flecainide in children.

Main Methods:

• Review of medication administration records in pediatric wards.
• Analysis of reported dispensing and administration errors.
• Identification of common error types, such as incorrect dosage or administration technique.

Main Results:

• Multiple errors were identified in the preparation and administration of flecainide suspension.
• Common errors included incorrect volume measurements and deviations from prescribed schedules.
• These errors may impact therapeutic efficacy and patient safety.

Conclusions:

• Errors in flecainide suspension administration in children are a significant concern.
• Improved training and standardized protocols are necessary to minimize medication errors.
• Further research into optimal pediatric dosing strategies for flecainide suspension is warranted.